Home > Nonmedical use of prescription drugs in the European Union.

Novak, Scott P and Hakansson, Anders and Martinez Raga, Jose and Reimer, Jens and Krotki, Karol and Varughese, Sagan [Biomed Central] . (2016) Nonmedical use of prescription drugs in the European Union. BioMed Central. BMC Psychiatry, 16 (274) DOI: 10.1186/s12888-016-0909-3

URL: http://bmcpsychiatry.biomedcentral.com/articles/10...

Background: Nonmedical prescription drug use (NMPDU) refers to the self-treatment of a medical condition using medication without a prescriber’s authorization as well as use to achieve euphoric states. This article reports data from a cross-national investigation of NMPDU in five European Countries, with the aim to understand the prevalence and characteristics of those engaging in NMPDU across the EU.

Methods: A parallel series of self-administered, cross-sectional, general population surveys were conducted in 2014. Data were collected using multi-stage quota sampling and then weighted using General Exponential Model. A total of 22,070 non-institutionalized participants, aged 12 to 49 years, in 5 countries: Denmark, Germany, Great Britain, Spain, and Sweden.

Results: Lifetime and past-year prevalence of nonmedical prescription drug use was estimated for opioids (13.5 and 5.0 %), sedatives (10.9 and 5.8 %), and stimulants (7.0 and 2.8 %). Germany exhibited the lowest levels of NMPDU, with Great Britain, Spain, and Sweden having the highest levels. Mental and sexual health risk factors were associated with an increased likelihood of past-year nonmedical prescription drug use. Among past-year users, about 32, 28, and 52 % of opioid, sedative, and stimulant nonmedical users, respectively, also consumed illicit drugs. Social sources (sharing by friends/family) were the most commonly endorsed methods of acquisition, ranging from 44 % (opioids) to 62 % (sedatives). Of interest is that Internet pharmacies were a common source of medications for opioids (4.1 %), stimulants (7.6 %), and sedatives (2.7 %).

Conclusions: Nonmedical prescription drug use was reported across the five EU countries we studied, with opioids and sedatives being the most prevalent classes of prescription psychotherapeutics. International collaborations are needed for continued monitoring and intervention efforts to target population subgroups at greatest risk for NMDU.

Item Type:Evidence resource
Drug Type:Prescription/Over the counter
Intervention Type:AOD prevention, AOD disorder harm reduction
Source:Biomed Central
Publisher:BioMed Central
Subjects:A Substance use, abuse, and dependence > Prevalence
E Concepts in biomedical areas > Substance by legal status > Prescription drug (medicine / medication)
J Health care, prevention and rehabilitation > Risk and protective factors > Risk factors
MP-MR Policy, planning, economics, work and social services > Marketing and public relations (advertising) > Internet retailing (online sales / dark web)
VA Geographic area > Europe

Repository Staff Only: item control page